Anti-RANKL antibody [12A668]

Name Anti-RANKL antibody [12A668]
Supplier Abcam
Catalog ab45039
Prices $390.00
Sizes 100 µg
Host Mouse
Clonality Monoclonal
Isotype IgG1
Clone 12A668
Applications ICC/IF ICC/IF WB IHC-P
Species Reactivities Mouse, Human
Antigen Bacterially expressed fusion protein, corresponding to amino acids 1-317 of Mouse RANKL
Description Mouse Monoclonal
Gene TNFSF11
Conjugate Unconjugated
Supplier Page Shop

Product images


Product References

Low-intensity pulsed ultrasound accelerates tooth movement via activation of the - Low-intensity pulsed ultrasound accelerates tooth movement via activation of the

Xue H, Zheng J, Cui Z, Bai X, Li G, Zhang C, He S, Li W, Lajud SA, Duan Y, Zhou H. PLoS One. 2013 Jul 23;8(7):e68926.

Role of RANK, RANKL, OPG, and CXCR4 tissue markers in predicting bone metastases - Role of RANK, RANKL, OPG, and CXCR4 tissue markers in predicting bone metastases

Ibrahim T, Sacanna E, Gaudio M, Mercatali L, Scarpi E, Zoli W, Serra P, Ricci R, Serra L, Kang Y, Amadori D. Clin Breast Cancer. 2011 Dec;11(6):369-75.

Gamma-glutamyltranspeptidase stimulates receptor activator of nuclear - Gamma-glutamyltranspeptidase stimulates receptor activator of nuclear

Niida S, Kawahara M, Ishizuka Y, Ikeda Y, Kondo T, Hibi T, Suzuki Y, Ikeda K, Taniguchi N. J Biol Chem. 2004 Feb 13;279(7):5752-6. Epub 2003 Nov 21.

Gene expression of osteoclast differentiation factor is induced by - Gene expression of osteoclast differentiation factor is induced by

Kikuchi T, Matsuguchi T, Tsuboi N, Mitani A, Tanaka S, Matsuoka M, Yamamoto G, Hishikawa T, Noguchi T, Yoshikai Y. J Immunol. 2001 Mar 1;166(5):3574-9.

Tumor necrosis factor receptor family member RANK mediates osteoclast - Tumor necrosis factor receptor family member RANK mediates osteoclast

Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I, Wang L, Xia XZ, Elliott R, Chiu L, Black T, Scully S, Capparelli C, Morony S, Shimamoto G, Bass MB, Boyle WJ. Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3540-5.